Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ACT4RHD: Adaptive Collaborative Trial for Rheumatic Heart Disease

NCT07830108 is registered in ClinicalTrials.gov with Starship Child Health, Te Toka Tumai Auckland as lead sponsor.

NCT NCT07830108
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07830108 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ACT4RHD: Adaptive Collaborative Trial for Rheumatic Heart Disease
Lead sponsor
Starship Child Health, Te Toka Tumai Auckland
Phase
Phase 3
Overall status
Not yet recruiting
Start date
December 31, 2026
Completion date
December 31, 2036
Enrollment
600 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute rheumatic fever, rheumatic fever, rheumatic heart disease, rheumatic heart disease in children